Tumor-intrinsic expression of signal regulatory protein α contributes to the suppression of anti-tumor immune responses
Year: 2026
Type: article
Abstract: SIRPα is a well-characterized inhibitory receptor on myeloid immune cells. However, human and mouse melanoma cells can also express high levels of SIRPα. Whether and how melanoma cell-intrinsic SIRPα contributes to tumor progression and anti-tumor immunity remains underexplored. Here, we identify a role of tumor cell-intrinsic SIRPα in suppressing immune recruitment and activation. SIRPα deletion in melanoma cells enhances tumor control and increases immune infiltration. Transcriptomic analyses reveal that loss of tumor cell-intrinsic SIRPα upregulates the chemokine CXCL10 in both human and mouse melanoma cells. Notably, Cxcl10 knockdown in SIRPα-deficient melanoma partially rescues tumor growth and reduces CD8 + T cell infiltration, mirroring the phenotype of SIRPα-expressing tumors and indicating that tumor cell-intrinsic SIRPα promotes immune evasion by suppressing Cxcl10 -mediated T cell recruitment. Our study uncovers an unrecognized mechanism of SIRPα-mediated immune suppression and highlights SIRPα silencing as a potential therapeutic strategy to enhance immune infiltration and T cell-mediated tumor control across SIRPα-expressing cancers.
Source: Cell Reports
Authors: Chien-Huan Weng, Chana Schochet, Vincent Panneton, Anais Assouvie, Shabnam Eghbali, Sébastien Monette, Cailian Liu, Yacine Marouf, Levi Mangarin, Lucia Morgado-Palacin, Parwiz Abrahimi, Jonathan F. Khan, Christopher S. Hackett, Daniel Hua, Qianqian Lin, Linda Hamadene, Pamela M. Holland, Jedd D. Wolchok, Taha Merghoub
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,620
OpenAlex ID: W7162801869
